Symbiotec Pharmalab Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Symbiotec Pharmalab Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10884
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Symbiotec Pharmalab Ltd (Symbiotec) is a medical laboratory that manufactures active pharmaceutical ingredients. The laboratory develops, produces and markets research-based cortico steroids and steroid-hormone APIs. Its cortico-steroids APIs include clobetasol propionate, betamethasone dipropionate, budesonide, clobetasone butyrate, betamethasone sodium phosphate, betamethasone valerate, and clopredno, among others. Symbiotec offers hormones APIs such as conjugated estrogens, desogestrel, esterified estrogen, estrone, drospirenone, estradiol and derivatives, ethinyl estradiol, ethisterone and ethynodiol diacetate. The laboratory’s other products include abiraterone acetate, exemestane and rocuronium bromide. It operates its manufacturing unit in Pigdamber and Pathampur, India. The laboratory markets its products in different parts of India. Symbiotec is headquartered in Indore, Madhya Pradesh, India.

Symbiotec Pharmalab Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Symbiotec Pharmalab Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Symbiotec Pharmalab Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Symbiotec Pharmalab Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Symbiotec Pharmalab Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Symbiotec Pharmalab Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Symbiotec Pharmalab Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Private Equity 10
Actis Advisers Plans to Sell Symbiotec Pharmalab 10
Baring Private Equity Asia May Acquire Controlling Stake in Symbiotec Pharmalab from Actis Capital 11
Actis Completes Acquisition Of Interest In Symbiotec Pharmalab For US$48 Million 13
Symbiotec Pharmalab Ltd – Key Competitors 14
Symbiotec Pharmalab Ltd – Key Employees 15
Symbiotec Pharmalab Ltd – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Symbiotec Pharmalab Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Symbiotec Pharmalab Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Symbiotec Pharmalab Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Symbiotec Pharmalab Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Symbiotec Pharmalab Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Symbiotec Pharmalab Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Actis Advisers Plans to Sell Symbiotec Pharmalab 10
Baring Private Equity Asia May Acquire Controlling Stake in Symbiotec Pharmalab from Actis Capital 11
Actis Completes Acquisition Of Interest In Symbiotec Pharmalab For US$48 Million 13
Symbiotec Pharmalab Ltd, Key Competitors 14
Symbiotec Pharmalab Ltd, Key Employees 15
Symbiotec Pharmalab Ltd, Other Locations 16

List of Figures
Symbiotec Pharmalab Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Symbiotec Pharmalab Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Symbiotec Pharmalab Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Symbiotec Pharmalab Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Symbiotec Pharmalab Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Symbiotec Pharmalab Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Symbiotec Pharmalab Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Symbiotec Pharmalab Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Symbiotec Pharmalab Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Tower One Wireless Corp (TO):製薬・医療:M&Aディール及び事業提携情報
    Summary Tower One Wireless Corp (Tower One), formerly Pacific Therapeutics Ltd, is a telecom infrastructure company that owns and operates cellular network infrastructure sites. The company’s services include tower construction, site acquisition and zoning, staffing, and RF tech and electrical. Its …
  • Bank Of The Philippine Islands:企業の戦略・SWOT・財務分析
    Bank Of The Philippine Islands - Strategy, SWOT and Corporate Finance Report Summary Bank Of The Philippine Islands - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Ascletis Inc-製薬・医療分野:企業M&A・提携分析
    Summary Ascletis Inc (Ascletis) is a healthcare company that provides therapeutics for cancer and infectious diseases. The company offers discovery, demonstration of global partnering, clinical proof-of-concept, and research and development services of novel therapeutics for life-threatening disease …
  • Genisphere LLC:医療機器:M&Aディール及び事業提携情報
    Summary Genisphere LLC (Genisphere) is a nanotechnology company that provides DNA-based targeted drug delivery solutions. The company utilizes its proprietary 3DNA platform which enables the application in gene delivery, biologics, small molecules, and RNAi therapeutics. It develops pipeline product …
  • Otter Tail Corp (OTTR):企業の財務・戦略的SWOT分析
    Otter Tail Corp (OTTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Kotak Mahindra Bank Ltd (KOTAKBANK):企業の財務・戦略的SWOT分析
    Kotak Mahindra Bank Ltd (KOTAKBANK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Vaxart Inc (VXRT):製薬・医療:M&Aディール及び事業提携情報
    Summary Vaxart Inc (Vaxart) is a clinical stage biotechnology company which develops oral recombinant protein vaccines based on its proprietary oral vaccine delivery platform to treat infections. The company develops tablet vaccines for seasonal and pandemic influenza, norovirus, and respiratory syn …
  • NIH Office of Technology Transfer:製薬・医療:M&Aディール及び事業提携情報
    Summary NIH Office of Technology Transfer (NIH OTT), a subsidiary of National Institutes of Health is a healthcare service provider that evaluates, protects, markets, licenses, monitors, and manages NIH and FDA discoveries, inventions, and other intellectual property. The center discovers new biolog …
  • Photocure ASA (PHO):企業の財務・戦略的SWOT分析
    Photocure ASA (PHO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Golden Meditech Holdings Ltd (801):医療機器:M&Aディール及び事業提携情報
    Summary Golden Meditech Holdings Ltd (Golden Meditech) is a medical equipment provider that provides blood stem cells storage and hospital management solutions. The company provides autologous blood recovery systems. It offers hospital management, medical insurance administration and blood bank serv …
  • BioNano Genomics Inc:医療機器:M&Aディール及び事業提携情報
    Summary BioNano Genomics Inc (BioNano) is a developer of technology platform to analyze the segments of genomic DNA and other structural variations. The company's products include irys chip, saphyr, genome mapping systems and prep kits. Its saphyr offers breakthrough speed and throughput with unmatc …
  • Immucor, Inc.:企業の戦略的SWOT分析
    Immucor, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • The GPT Group:企業のM&A・事業提携・投資動向
    The GPT Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The GPT Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Aditya Birla Retail Limited:企業の戦略的SWOT分析
    Aditya Birla Retail Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Aldi Inc:企業の戦略的SWOT分析
    Aldi Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • CollPlant Ltd:医療機器:M&Aディール及び事業提携情報
    Summary CollPlant Ltd (CollPlant) is a regenerative medicine company that develops and commercializes tissue repair products. The company’s product categories include orthobiologics, wound care, and pipeline products. Its orthobiologics products comprise VergenixSTR and VergenixBVF. CollPlant’s woun …
  • Otto Bock HealthCare GmbH-医療機器分野:企業M&A・提携分析
    Summary Otto Bock HealthCare GmbH (Otto Bock), a group company of Otto Bock Holding GmbH & Co. KG, is a medical device company that manufactures and distributes prosthetic and orthotic devices. It also offers mobility and seating solutions for the physically disabled adults and children. The product …
  • Industrias Penoles SAB de CV:企業の戦略・SWOT・財務情報
    Industrias Penoles SAB de CV - Strategy, SWOT and Corporate Finance Report Summary Industrias Penoles SAB de CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • China Health Group Inc (8225):企業の財務・戦略的SWOT分析
    China Health Group Inc (8225) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Achaogen Inc (AKAO):製薬・医療:M&Aディール及び事業提携情報
    Summary Achaogen Inc (Achaogen) is a biopharmaceutical company that discovers, develops and commercializes novel anti bacterials for the treatment of multi-drug resistant and gram-negative infections. The company offers plazomicin for the treatment of serious bacterial infections including urinary t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆